In Vivo Efficacy of the New Ketolide Telithromycin (HMR 3647) in Murine Infection Models

We compared the oral antibacterial activities of telithromycin (HMR 3647), a new ketolide drug, in different infections induced in mice by Staphylococcus aureus, Streptococcus pneumoniae, streptococci, enterococci, and Haemophilus influenzae with those of various macrolides and pristinamycin. Unlike...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Bonnefoy, Alain, Guitton, Michele, Delachaume, Carole, Le Priol, Pascal, Girard, Anne-Marie
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90532/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11353612/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.6.1688-1692.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!